O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+16.19%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.79B
AUM Growth
+$8.79B
(+13%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
37.24%
Holding
144
New
16
Increased
26
Reduced
29
Closed
10
Top Buys
| 1 |
Centene
CNC
|
$118M |
| 2 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$74.8M |
| 3 |
Merck
MRK
|
$69.9M |
| 4 |
AET
Aetna Inc
AET
|
$64.6M |
| 5 |
Viatris
VTRS
|
$50.7M |
Top Sells
| 1 |
Amgen
AMGN
|
$147M |
| 2 |
Neurocrine Biosciences
NBIX
|
$73.1M |
| 3 |
Intuitive Surgical
ISRG
|
$72.9M |
| 4 |
AGN
Allergan plc
AGN
|
$69.8M |
| 5 |
AbbVie
ABBV
|
$55.1M |
Sector Composition
| 1 | Healthcare | 93.33% |
| 2 | Financials | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Jazz Pharmaceuticals
JAZZ
$7.75B
| $53.9M | 0.61% | 371,400 | – | – |
|
|
52
Viatris
VTRS
$12.3B
| $50.7M | 0.57% | +1,300,000 | New | +$50.7M |
|
53
UnitedHealth
UNH
$281B
| $48.6M | 0.55% | 296,400 | – | – |
|
|
LUMO
54
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $48M | 0.54% | 1,991,700 | – | – |
|
55
Stryker
SYK
$150B
| $41.6M | 0.47% | 316,300 | – | – |
|
56
Acadia Pharmaceuticals
ACAD
$4.38B
| $40.2M | 0.46% | +1,169,000 | New | +$40.2M |
|
|
GBT
57
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $40M | 0.45% | +1,084,500 | New | +$40M |
|
|
58
Intuitive Surgical
ISRG
$170B
| $38.6M | 0.44% | 50,400 -95,100 | -65% | -$72.9M |
|
59
Cooper Companies
COO
$13.4B
| $38.1M | 0.43% | 190,800 -59,300 | -24% | -$11.9M |
|
60
Intellia Therapeutics
NTLA
$1.22B
| $37.5M | 0.43% | 2,662,180 | – | – |
|
|
DERM
61
DELISTED
Dermira, Inc.
DERM
| $34.9M | 0.4% | 1,023,673 +598,073 | +141% | +$20.4M |
|
|
ONC
62
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $33.1M | 0.38% | 903,700 | – | – |
|
63
Assembly Biosciences
ASMB
$190M
| $32M | 0.36% | 1,257,300 -139,800 | -10% | -$3.56M |
|
64
Sarepta Therapeutics
SRPT
$1.78B
| $31.2M | 0.35% | +1,054,300 | New | +$31.2M |
|
|
MNTA
65
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $28.2M | 0.32% | 2,109,068 -842,900 | -29% | -$11.3M |
|
66
Select Medical
SEM
$1.61B
| $27.9M | 0.32% | 2,086,300 +1,254,400 | +151% | +$16.7M |
|
|
RDUS
67
DELISTED
Radius Health, Inc.
RDUS
| $27.2M | 0.31% | +704,100 | New | +$27.2M |
|
|
OBSV
68
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $27.1M | 0.31% | +2,605,531 | New | +$27.1M |
|
69
Cartesian Therapeutics
RNAC
$261M
| $26.4M | 0.3% | 1,842,797 | – | – |
|
|
BLUE
70
DELISTED
bluebird bio
BLUE
| $25.8M | 0.29% | 283,800 | – | – |
|
71
Iovance Biotherapeutics
IOVA
$807M
| $25.2M | 0.29% | 3,382,900 | – | – |
|
72
Galapagos
GLPG
$2.07B
| $24.4M | 0.28% | 283,500 | – | – |
|
|
IMGN
73
DELISTED
Immunogen Inc
IMGN
| $23.6M | 0.27% | 6,095,647 | – | – |
|
74
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $22.9M | 0.26% | 1,084,400 +234,300 | +28% | +$4.96M |
|
|
OTIC
75
DELISTED
Otonomy, Inc.
OTIC
| $22.7M | 0.26% | 1,850,094 | – | – |
|